Literature DB >> 28101191

MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1.

Jian Liu1, Bohua Chen1, Bin Yue1, Junde Yang1.   

Abstract

MicroRNAs (miRNAs) are a class of small non-coding RNAs that function as critical gene regulators by targeting the 3' untranslated region (UTR) of mRNA, causing translational repression or mRNA degradation. Deregulation of specific miRNAs, including miR-212, has been identified in patients with osteosarcoma. However, the underlying mechanism is yet to be fully elucidated. The present study aimed to reveal the regulatory mechanism of miR-212 in osteosarcoma cell viability and migration. Quantitative polymerase chain reaction data revealed that miR-212 was significantly downregulated in osteosarcoma tissues compared with normal bone tissues. miR-212 was also downregulated in osteosarcoma cell lines compared with normal osteoblast cell lines. Overexpression of miR-212 significantly suppressed the viability and migration of human osteosarcoma MG-63 and Saos-2 cell lines. In addition, forkhead box protein A1 (FOXA1), an oncogene in osteosarcoma, was predicted to be a putative target of miR-212 by bioinformatical analysis. Furthermore, luciferase reporter assay data confirmed that miR-212 could directly bind to the seed sequences within the 3'UTR of FOXA1 mRNA, and miR-212 negatively mediated the protein levels of FOXA1 in osteosarcoma MG-63 and Saos-2 cells. Moreover, knockdown of FOXA1 also led to a significant decrease in the viability and migration of osteosarcoma MG-63 and Saos-2 cells and the expression levels of FOXA1 were significantly upregulated in osteosarcoma tissues and cell lines. These data suggest that miR-212 inhibits the viability and migration of osteosarcoma cells by targeting FOXA1. Accordingly, miR-212 may become a potential candidate for osteosarcoma therapy.

Entities:  

Keywords:  forkhead box protein A1; microRNA-212; migration; osteosarcoma; proliferation

Year:  2016        PMID: 28101191      PMCID: PMC5228200          DOI: 10.3892/etm.2016.3880

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  22 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells.

Authors:  Ling Xu; Feng Wang; Xuan-Fu Xu; Wen-Hui Mo; Yu-Jing Xia; Rong Wan; Xing-Peng Wang; Chuan-Yong Guo
Journal:  Med Oncol       Date:  2010-11-05       Impact factor: 3.064

3.  FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells.

Authors:  Lu Zheng; Bo Qian; Duo Tian; Tong Tang; Shengyun Wan; Lei Wang; Lixin Zhu; Xiaoping Geng
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.

Authors:  Wenhuan Guo; Anne L Keener; Yifeng Jing; Liquan Cai; Junkui Ai; Jian Zhang; A L Fisher; Guohui Fu; Zhou Wang
Journal:  Prostate       Date:  2015-03-23       Impact factor: 4.104

5.  miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.

Authors:  Jong-Kook Park; Jon C Henry; Jinmai Jiang; Christine Esau; Yuriy Gusev; Megan R Lerner; Russell G Postier; Daniel J Brackett; Thomas D Schmittgen
Journal:  Biochem Biophys Res Commun       Date:  2011-02-15       Impact factor: 3.575

6.  MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1.

Authors:  Yuan Li; Deqiang Zhang; Chengwen Chen; Zhenchao Ruan; Yao Li; Yan Huang
Journal:  Mol Biol Cell       Date:  2012-02-22       Impact factor: 4.138

Review 7.  MicroRNAs in cell proliferation, cell death, and tumorigenesis.

Authors:  H-W Hwang; J T Mendell
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

8.  MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.

Authors:  Changwei Dou; Yufeng Wang; Chao Li; Zhikui Liu; Yuli Jia; Qing Li; Wei Yang; Yingmin Yao; Qingguang Liu; Kangsheng Tu
Journal:  Oncotarget       Date:  2015-05-30

9.  miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.

Authors:  Yong Zhou; Zufa Huang; Song Wu; Xiaofang Zang; Min Liu; Jian Shi
Journal:  J Exp Clin Cancer Res       Date:  2014-01-27

10.  Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro.

Authors:  Zhiqiang Chang; Lifeng Huo; Kun Li; Yiming Wu; Zhenming Hu
Journal:  ScientificWorldJournal       Date:  2014-06-09
View more
  7 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.

Authors:  Jiang-Hua Dai; Wen-Zhou Huang; Chen Li; Jun Deng; Si-Jian Lin; Jun Luo
Journal:  Cell Cycle       Date:  2019-08-21       Impact factor: 4.534

3.  Long non-coding RNA TUG1 promotes osteosarcoma cell proliferation and invasion through inhibition of microRNA-212-3p expression.

Authors:  Heng Li; Guofeng Tian; Feipeng Tian; Lin Shao
Journal:  Exp Ther Med       Date:  2018-05-24       Impact factor: 2.447

4.  Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p.

Authors:  Shenglong Li; Ke Zheng; Yi Pei; Wei Wang; Xiaojing Zhang
Journal:  Aging (Albany NY)       Date:  2019-12-04       Impact factor: 5.682

Review 5.  The functions and targets of miR-212 as a potential biomarker of cancer diagnosis and therapy.

Authors:  Wenjun Chen; Jing Song; Hongjun Bian; Xia Yang; Xiaoyu Xie; Qiang Zhu; Chengyong Qin; Jianni Qi
Journal:  J Cell Mol Med       Date:  2020-01-13       Impact factor: 5.310

6.  Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.

Authors:  Xinle Luo; Jiuyang Tang; Huabing Xuan; Jianlin Liu; Xi Li
Journal:  Med Sci Monit       Date:  2020-02-26

7.  MicroRNA-935 Inhibits Proliferation and Invasion of Osteosarcoma Cells by Directly Targeting High Mobility Group Box 1.

Authors:  Zhiqiang Liu; Qiang Li; Xin Zhao; Bin Cui; Libo Zhang; Qiang Wang
Journal:  Oncol Res       Date:  2018-02-22       Impact factor: 5.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.